4Filing Date: Mar 17, 2026

Guardant Health (GH) 4: Kalia Kumud bought 12,856 shares of Common Stock at $N/A on… (Mar 17, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001927831-26-000008
Total Value$584.7K
Trades5
Insiders1

Transaction Details

Kalia Kumud
Chief Information Officer·Direct
Exercise · Dispose
Performance-Based Restricted Stock UnitsDerivative
Shares-12.86K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateMar 15, 2026
Footnotes ▸

This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. | Not applicable for Restricted Stock Units.

Kalia Kumud
Chief Information Officer·Direct
Exercise · Acquire
Common Stock
Shares+12.86K
Price$0.00
Total Value$0
Shares Owned After50.50K
Transaction DateMar 15, 2026
Kalia Kumud
Chief Information Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-6.84K
Price$85.49
Total Value$584.7K
Shares Owned After44.30K
Transaction DateMar 15, 2026
Footnotes ▸

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Kalia Kumud
Chief Information Officer·Direct
Exercise · Acquire
Common Stock
Shares+637
Price$0.00
Total Value$0
Shares Owned After51.14K
Transaction DateMar 15, 2026
Kalia Kumud
Chief Information Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-637
Price$0.00
Total Value$0
Shares Owned After638
Transaction DateMar 15, 2026
Footnotes ▸

This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. | Not applicable for Restricted Stock Units.

Post-Transaction Holdings

Kalia Kumud · Chief Information Officer
SecuritySharesChange
Common Stock50.50K+6.65K (15.18%)
Performance-Based Restricted Stock Units0-12.86K (-100.00%)
Restricted Stock Units638-637 (-49.96%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-03-15 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Kalia Kumud CIK: 0001927831 Role: Officer (Chief Information Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-03-15 | Code: M (Exercise of derivative) Shares: +12,856 | Price: $0.00 Shares Owned After: 50,499 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-03-15 | Code: M (Exercise of derivative) Shares: +637 | Price: $0.00 Shares Owned After: 51,136 | Ownership: D (Direct) [Transaction #3] Security: Common Stock Date: 2026-03-15 | Code: F (Payment of exercise/tax) Shares: -6,839 | Price: $85.49 Total Value: $584,666.11 Shares Owned After: 44,297 | Ownership: D (Direct) Footnotes: [F1] These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. --- Derivative Transactions --- [Transaction #1] Security: Performance-Based Restricted Stock Units Date: 2026-03-15 | Code: M (Exercise of derivative) Shares: -12,856 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F2] This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. [F3] Not applicable for Restricted Stock Units. [Transaction #2] Security: Restricted Stock Units Date: 2026-03-15 | Code: M (Exercise of derivative) Shares: -637 | Price: $0.00 Shares Owned After: 638 | Ownership: D (Direct) Footnotes: [F4] This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. [F3] Not applicable for Restricted Stock Units. --- Footnotes (Complete Index) --- F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. F2: This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. F3: Not applicable for Restricted Stock Units. F4: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. --- Signature --- /s/ /s/ John G. Saia, as attorney-in-fact for Kumud Kalia (2026-03-17)

keid analysis is for reference only and does not constitute investment advice.